Corcept Therapeutics Receivables 2010-2024 | CORT

Corcept Therapeutics receivables for the quarter ending September 30, 2024 were $0.060B, a 72.46% increase year-over-year.

  • Corcept Therapeutics receivables for 2023 were $0.041B, a 32.41% increase from 2022.
  • Corcept Therapeutics receivables for 2022 were $0.031B, a 12.42% increase from 2021.
  • Corcept Therapeutics receivables for 2021 were $0.028B, a 5.45% increase from 2020.

Corcept Therapeutics Receivables 2010-2024 | CORT

  • Corcept Therapeutics receivables for 2023 were $0.041B, a 32.41% increase from 2022.
  • Corcept Therapeutics receivables for 2022 were $0.031B, a 12.42% increase from 2021.
  • Corcept Therapeutics receivables for 2021 were $0.028B, a 5.45% increase from 2020.